Approval of Product under Voucher: Rare Pediatric Disease Priority Review Voucher; Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc)

TitleApproval of Product under Voucher: Rare Pediatric Disease Priority Review Voucher; Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc)
ToC Doc Rare Pediatric Disease Priority Review Voucher; Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc)
Docket Number2024-15695
Type Notice
Subject Approval of Product under Voucher:
Rare Pediatric Disease Priority Review Voucher; Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc)
Publication Date2024-07-17
Last Updated Date 2024-07-16 08:28:06 -0400
Last Public Inspection2024-07-16
Filed At2024-07-16T08:45:00.000-04:00
PDF 2024-15695_PI.pdf (87738 bytes)
Download TXT / HTML / JSON
Number of Pages 2
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021